Northwest Biotherapeutics Market Cap

Northwest Biotherapeutics has a market cap or net worth of $360.57 million as of March 9, 2026. Its market cap has increased by 4.78% in one year.

Market Cap

360.57M

Enterprise Value

446.45M

Revenue

937.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.23

Market Cap Chart

Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 360.57M, an increase of 3,404.29%. That is a compound annual growth rate of 15.80%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	360.57M	0.61%
Dec 31, 2025	358.39M	-1.53%
Dec 31, 2024	363.95M	-55.71%
Dec 29, 2023	821.84M	-1.00%
Dec 30, 2022	830.10M	25.14%
Dec 31, 2021	663.34M	-47.13%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CytoDyn	296.04M
Silence Therapeutics	259.79M
Vaxart	173.15M
HST Global	88.19M
BioStem Technologies	87.58M
Nuo Therapeutics	60.36M
Vicapsys Life Sciences	48.56M
Cell Source	48.33M

Market Cap Rankings